{"title":"[The use of ranitidine in antineoplastic polychemotherapy].","authors":"A D'Agata","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The Author analyzes the ranitidine's role in course of antiblastic treatments. The drug, administrated the night orally at the dose of 300 mgr/pro die, improves the tolerance of antineoplastic drugs and determines less incidence of gastric injuries in oncologic patients.</p>","PeriodicalId":77541,"journal":{"name":"Giornale italiano di oncologia","volume":"10 4","pages":"125-7"},"PeriodicalIF":0.0000,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di oncologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The Author analyzes the ranitidine's role in course of antiblastic treatments. The drug, administrated the night orally at the dose of 300 mgr/pro die, improves the tolerance of antineoplastic drugs and determines less incidence of gastric injuries in oncologic patients.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
